My Favorite Web Sites
Angelfire - Free Home Pages
Free Web Building Help
In 1986/87, Aids Research developed mp120, a HIV virus that was sheaved with a modified protein. When mp120 was introduced to a HIV-infected immune system, the over-sized HIV virus was quickly detected and attacked by the bodies T-cells. And once exposed (to the over-sized HIV virus), the human- immune system developed the ability to detect the smaller, prior-to undetected HIV viruses. The mp120 research is a valuable attainment and a hallmark in micro-sized blood infections. Commissioned with billions of dollars in AIDS research funding, a successful introduction/cure by mp120 could have halted other established AIDS research founding. Mp120 Research became directed towards developing an Aids Vaccine. I believe it was in 1990, monks at a Californian Monastery, all of whom were HIV negative, agreed to test a new mp120 AIDS vaccine and there the story ended! Was research shut down because the virus continued to mutate? To mutate a HIV virus into having a modified protein, a HIV virus was placed into a caterpillar and when the virus was later withdrawn, the virus was larger and sheaved with a modified protein. The body’s T-cells can not detect a HIV virus. The virus is so small it can attack and eventually kill the white side of a T-cell, which is what rebuilds, without being detected by the red side of the T-cell, which (collectively) is what fight infection. But the T-cells could detect the larger mp120 virus and in clinical research the T-cells learnt to detect the smaller, prior to invisible HIV virus. This is a great defense improvement in fighting the HIV virus. I wonder if the new anti-retro-viral medicine has given the body (this same advantage of) the ability to detect the HIV virus? If a patient’s immune system is HIV positive, there is no risk to the patient in receiving the mp120 protein sheaved virus. Both the anti-retro-viral medicine and the protein sheaved HIV virus are great advances. Free the mp120 for further clinical research. Give a one-time injection of mp120 to people in Africa who have AIDS or who are HIV positive and also re-evaluate additional mp120 treatment/injection for people who all on the Anti-retro-viral medicine. The moral or ethical concerns of administering mp120 is that if a person who has AIDS or who is HIV positive and has received mp120 injection, passes the AIDS virus to second party, they will not have passed the improved ability of the T-cells to detect the invisibly small HIV virus. Continue clinical research here and abroad. Thank you for visiting my page at Angelfire.
